SCHEMBL23964960

SCHEMBL23964960

CC1(C)OB(c2nc(-c3ccccc3)nc(-c3ccc(-c4ccccc4)c4ccccc34)n2)OC1(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 2/20 0.43
LIPG Q9Y5X9 2/20 0.43
L3MBTL1 Q9Y468 3/20 0.38
TSHR P16473 3/20 0.33
MAPK1 P28482 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
ATM Q13315 2/20 0.33
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965122 0.89 ALDH1A1 (0.46) LPLLIPGL3MBTL1TSHRMAPK1
SCHEMBL24264650 0.89 LPL (0.45) LPLLIPGL3MBTL1TSHRMAPK1
SCHEMBL15803154 0.88 LPL (0.53) LPLLIPGL3MBTL1MAPK1ADORA3
SCHEMBL23965139 0.88 ALDH1A1 (0.45) LPLLIPGL3MBTL1TSHRMAPK1
SCHEMBL22117456 0.85 LIPG (0.59) LPLLIPGL3MBTL1HSD17B10ADORA3
SCHEMBL23327890 0.85 LIPG (0.59) LPLLIPGL3MBTL1HSD17B10ADORA3
SCHEMBL18347059 0.84 LPL (0.44) LPLLIPGL3MBTL1TSHRMAPK1
SCHEMBL29927412 0.84 LPL (0.44) LPLLIPGL3MBTL1TSHRMAPK1
SCHEMBL23327819 0.84 LIPG (0.64) LPLLIPGL3MBTL1ATMMEN1
SCHEMBL23965374 0.84 LPL (0.42) LPLLIPGL3MBTL1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNL2, MCM6, CRY1 LPL 2546/4885LIPG 3610/4885L3MBTL1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.